Aliya Asher

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Thomas Werfel, Gary Layton, Michael Yeadon et al. · Journal of Allergy and Clinical Immunology · 2018 · 129 citations

Drug Hypersensitivity, Allergy, Atopic Dermatitis +7

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

Cris S. Constantinescu, Aliya Asher, Waldemar Fryze et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 103 citations · Full text

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

Stephen Macfarlane, Timo Grimmer, Ken Teo et al. · The Journal of Prevention of Alzheimer s Disease · 2025 · 29 citations · Full text

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

Thomas Werfel, Victoria Lynch, Aliya Asher et al. · Open Repository and Bibliography (University of Liège) · 2016 · 15 citations